NCAM1 and COVID-19: Using flow cytometry, two studies found an increased frequency of these adaptive NK cells, phenotyped by either CD56dimNKG2C+CD57+ or FcεRig-CD56+CD57+ cells, in severe but not in moderate COVID-19 patients (26, 29).